FDA Approves GLP-1 pill, Foundayo, for Weight Loss

Health & LifestyleNews
24

Listen to article (english)

Translate to Spanish or other 102 languages!

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes
The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problem. Image for illustration purposes

Mega Doctor News

- Advertisement -

Medical News Today

The Food and Drug Administration (FDA) has approved Eli Lilly’s once-daily oral GLP-1 receptor agonist, orforglipron, for adults with obesity, or overweight with weight-related medical problems.

This approval makes Eli Lilly’s oral GLP-1 receptor agonist, to be marketed as Foundayo, the second GLP-1 drug available in pill form, after Wegovy, which gained approval in December 2025.

- Advertisement -

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/fda-approves-oral-glp-1-pill-foundayo-for-weight-loss

Information source: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Texas AG Opens New Medicaid Fraud Investigations Based on Newly Released Federal Data

More Articles

Texas AG Opens New Medicaid Fraud Investigations Based on Newly Released Federal Data

 Attorney General Ken Paxton’s Healthcare Program Enforcement Division (“HPED”) has launched investigations into dozens of Medicaid providers across Texas. The investigations were launched by utilizing the U.S. Department of Health and Human Services’ (“HHS”) claims data that was released due to efforts by the Department of Government Efficiency (“DOGE”).

Donate Life Month Highlights Critical Need for Blood in Organ Transplants

Mega Doctor News McALLEN, Texas - Chris Connolly knows he wouldn’t be alive...

TMA Aligns With AMA in Lawsuit Challenging Alleged Out‑of‑Network Price‑Fixing Scheme

The Texas Medical Association (TMA) has joined a federal multidistrict litigation against MultiPlan (recently rebranded to Claritev) and major insurers

Ease Into Your Day: Stress‑Free Morning Habits

Trying to make your mornings less stressful? It’s easier said than done but finding ways to manage stress after your alarm goes off can make a difference in your overall health.
- Advertisement -